Singular Genomics Systems, Inc. Common Stock
OMIC
OMIC was delisted on the 20th of February, 2025.
62 hedge funds and large institutions have $27.3M invested in Singular Genomics Systems, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 21 reducing their positions, and 19 closing their positions.
125% more call options, than puts
Call options by funds: $27K | Put options by funds: $12K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less funds holding
Funds holding: 66 → 62 (-4)
21% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 19
24% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 21
38% less capital invested
Capital invested by funds: $43.8M → $27.3M (-$16.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$840K |
| 2 |
AI
Acuitas Investments
Seattle,
Washington
|
+$646K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$512K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$469K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$201K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.54M |
| 2 |
PA
Perceptive Advisors
New York
|
-$898K |
| 3 |
State Street
Boston,
Massachusetts
|
-$732K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$491K |
| 5 |
EWA
EP Wealth Advisors
Torrance,
California
|
-$491K |
OMIC Hedge Fund Activity: Q2 2023 in Review
62 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q2 2023, worth a combined $27.3M — down 38% from $43.8M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of OMIC and 15 opened new positions — a net loss of 4 holders — while 21 trimmed existing stakes and 16 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $840K. The largest seller was BlackRock, cutting an estimated $2.54M.
- 62 institutional investors held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q2 2023, down from 66 in Q1 2023.
- Funds reported $27.3M of Singular Genomics Systems, Inc. Common Stock stock for Q2 2023, down 38% quarter-over-quarter.
- 15 funds opened new Singular Genomics Systems, Inc. Common Stock positions in Q2 2023 and 19 closed out, a net change of -4 holders.
- The largest Singular Genomics Systems, Inc. Common Stock buyer in Q2 2023 was Millennium Management, an estimated $840K added.
- The largest Singular Genomics Systems, Inc. Common Stock seller in Q2 2023 was BlackRock, an estimated $2.54M sold.
Based on aggregated 13F filings for Q2 2023.